You are here: Simmaron ResearchPathogensViral Finding May Open Treatment Possibilities for 15-20K Chronic Fatigue Syndrome Patients in the U.S.Valganciclovir

Valganciclovir

August 1, 2013

0 Comments

valcyte molecule

Valganciclovir (Valcyte) is effective against HHV-6; (valaciyclovir) Valtrex is not

Print Friendly, PDF & Email

Donate Button

  • Another interesting article on the possible link between the virus and symptoms familiar to patient… ,
  • Dr. Mady Hornig (Columbia University), Simmaron Scientific Advisory Board member, shares interesting insights about… ,
  • In whatever way you and yours may be commemorating this day, Team Simmaron wishes you safety and celebration!… ,